Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Hypertrophic Burn Scars
NCT03935594Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2020
- Primary completion
- May 2021
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of platelet-rich plasma in Hypertrophic Scar (HS), sponsored by Vanderbilt University Medical Center. Primary endpoints: Patient and Observer Scar Assessment Scale at 2 months and Vancouver Scar Scale at 2 months. Started Sep 2020; status: terminated.
02
Drugs
platelet-rich plasma
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT03935594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935594.